Jul 4, 2023 | 2023, Press Releases, Scientific
The study was conducted by scientists at Philochem AG, the wholly owned Swiss subsidiary company of the Philogen group. The paper can be accessed on the Nature Chemistry website at the following link. Nat_chem_280223_press_releaseJun 1, 2023 | 2023, Press Releases, Scientific
Nidlegy™_CTCSA_Merck_Press_Release_ENGMay 26, 2023 | 2023, Press Releases, Scientific
230524_Philogen_STM_Press_ReleaseMar 28, 2023 | 2023, Press Releases, Scientific
The collaboration has focused on the use of Google’s Machine Learning models combined with Philochem’s DNA-Encoded Chemical Libraries. The research activity promises to have a direct impact on the discovery of novel tumor-targeting small organic ligands with broad...Feb 9, 2023 | 2023, Press Releases, Scientific
We are delighted to share the exciting journey of one of our talented PhD students Sara Puglioli, which has recently been covered in a CHEM article (Cell Press). Over the last years, Philochem AG has established industrial Ph.D. programs in collaboration with several...Feb 2, 2023 | 2023, Press Releases, Scientific
Philogen announces the publication of a study in the peer-reviewed journal “Pharmaceutics” describing the development and the in vitro/vivo characterization of a novel interferon-gamma (IFNg) based antibody fusion protein. The paper can be accessed from the...
Recent Comments